111 (NASDAQ:YI) Director Jian David Sun Sells 58,800 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 58,800 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $0.23, for a total transaction of $13,524.00. Following the completion of the sale, the director directly owned 413,211 shares of the company’s stock, valued at approximately $95,038.53. This represents a 12.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Thursday, June 11th, Jian David Sun sold 111,100 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00.
• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The stock was sold at an average price of $0.22, for a total value of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total value of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $7,905.60.

111 Stock Performance

YI opened at $4.45 on Wednesday. The company has a market capitalization of $39.09 million, a PE ratio of -3.18 and a beta of 0.60. The stock’s fifty day moving average is $5.84 and its 200-day moving average is $5.67. 111, Inc. Sponsored ADR has a one year low of $2.48 and a one year high of $11.17.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.